vs
Okeanis Eco Tankers Corp.（ECO）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Okeanis Eco Tankers Corp.的2.0倍（$772.1M vs $393.2M），过去两年Okeanis Eco Tankers Corp.的营收复合增速更高（20.5% vs 9.0%）
Okeanis Eco Tankers Corp是一家国际化航运企业，主营环保型油轮船队运营，提供原油及成品油的海上运输服务，覆盖全球主要贸易航线的能源及大宗商品客户，主打高能效低排放船舶设计，践行航运低碳发展目标。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
ECO vs RVTY — 直观对比
营收规模更大
RVTY
是对方的2.0倍
$393.2M
两年增速更快
ECO
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $393.2M | $772.1M |
| 净利润 | — | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 41.4% | 14.5% |
| 净利率 | — | 12.7% |
| 营收同比 | — | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECORVTY
| Q4 25 | $393.2M | $772.1M | ||
| Q3 25 | $308.0M | $698.9M | ||
| Q2 25 | $-49.0M | $720.3M | ||
| Q1 25 | $111.1M | $664.8M | ||
| Q4 24 | $413.1M | $729.4M | ||
| Q3 24 | $321.4M | $684.0M | ||
| Q2 24 | $232.4M | $691.7M | ||
| Q1 24 | — | $649.9M |
净利润ECORVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | — | $46.7M | ||
| Q2 25 | — | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | — | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | — | $26.0M |
毛利率ECORVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率ECORVTY
| Q4 25 | 41.4% | 14.5% | ||
| Q3 25 | 44.2% | 11.7% | ||
| Q2 25 | 101.1% | 12.6% | ||
| Q1 25 | 49.6% | 10.9% | ||
| Q4 24 | 48.7% | 16.3% | ||
| Q3 24 | 52.0% | 14.3% | ||
| Q2 24 | 56.7% | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率ECORVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）ECORVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $116.6M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $573.1M | $7.3B |
| 总资产 | $1.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ECORVTY
| Q4 25 | $116.6M | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | $59.8M | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $49.3M | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $92.8M | $2.0B | ||
| Q1 24 | — | $1.7B |
股东权益ECORVTY
| Q4 25 | $573.1M | $7.3B | ||
| Q3 25 | — | $7.4B | ||
| Q2 25 | $428.3M | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $410.4M | $7.7B | ||
| Q3 24 | — | $7.9B | ||
| Q2 24 | $432.6M | $7.9B | ||
| Q1 24 | — | $7.8B |
总资产ECORVTY
| Q4 25 | $1.2B | $12.2B | ||
| Q3 25 | — | $12.1B | ||
| Q2 25 | $1.1B | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | $1.1B | $12.4B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | $1.1B | $13.4B | ||
| Q1 24 | — | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $111.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流ECORVTY
| Q4 25 | $111.3M | $182.0M | ||
| Q3 25 | $132.2M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | $162.8M | $174.2M | ||
| Q3 24 | — | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | — | $147.6M |
自由现金流ECORVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率ECORVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度ECORVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率ECORVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECO
暂无分部数据
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
